Evaluation of Minimally Invasive Ilium Osteotomy and Its Bone Repairing Effect
Clinical Randomized Controlled Study on the Evaluation of Minimally Invasive Ilium Osteotomy and Its Bone Repairing Effect
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Li L Wanli, M.D.
- Phone Number: 13967116021
- Email: liwanli@furunmed.com
Study Contact Backup
- Name: Li L Hongmei
- Phone Number: 13857139616
- Email: lihongmei@furunmed.com
Study Locations
-
-
Zhe Jiang
-
Hangzhou, Zhe Jiang, China, 311100
- Recruiting
- Hangzhou Xinrun Medical Technology Co., Ltd.
-
Contact:
- Li L Wanli, M.D.
- Phone Number: 13967116021
- Email: liwanli@furunmed.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with clinical bone defects or need for bone fusion;
- Age 18 to 65, and gender is not limited;
- Informed consent has been signed.
Exclusion Criteria:
- Age less than 18 or greater than 65;
- Patients with severe deformities of the iliac bone or extensive defects of the iliac bone, which are not suitable for bone extraction;
- Patients with coagulation dysfunction;
- Patients who are unwilling to perform iliac bone extraction;
- BMI & lt; = 18.5 kg/m2;
- Patients with type I and type II diabetes;
- Osteoporosis(T & lt; = -2.5);
- Moderate and severe anemia(hemoglobin & lt; 9g/L) or hypoproteinemia(albumin & lt; 30g/L);
- Patients with malignant neoplasms; Patients with mental illness and those who are unconscious and unable to express themselves accurately.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Minimally invasive bone harvesting surgery
|
Minimally invasive bone harvesting surgery
|
|
Placebo Comparator: Traditional iliac crest bone harvesting surgery
|
The experimental group and the control group do not have special requirements; perform the surgery according to the normal operation methods of different sites.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the VAS score of pain in the donor site
Time Frame: 24 hours after the operation
|
the VAS score of pain in the donor site
|
24 hours after the operation
|
|
the comprehensive curative effect
Time Frame: 6 months after the operation
|
the healing rate of the bone graft site
|
6 months after the operation
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Yan Y Shigui, Professor, Chief Scientist
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 2019-254
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.